Literature DB >> 6572149

Induction of differentiation of human acute non-lymphocytic leukemia cells in primary culture by inducers of differentiation of human myeloid leukemia cell line HL-60.

Y Honma, Y Fujita, T Kasukabe, M Hozumi, K Sampi, M Sakurai, S Tsushima, H Nomura.   

Abstract

Leukemia cells from patients with acute non-lymphocytic leukemia were treated with various inducers of differentiation of the human promyelocytic leukemia cell line HL-60. All cells in 14 specimens tested underwent morphological, functional and histochemical changes after treatment with some inducers of differentiation of HL-60 cells, but the most effective inducer varied for different specimens. These results suggest that treatment with some inducers should be effective for inducing most acute myeloid leukemia cells to differentiate into morphologically and functionally mature granulocytes and macrophages.

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6572149     DOI： 10.1016/0277-5379(83)90424-8

Source DB:  PubMed          Journal:  Eur J Cancer Clin Oncol        ISSN： 0277-5379


  6 in total

1.  Localization of the cellular retinoic acid binding protein (CRABP) gene relative to the acute promyelocytic leukemia-associated breakpoint on human chromosome 15.

Authors:  A Geurts van Kessel; H de Leeuw; E J Dekker; L Rijks; N Spurr; D Ledbetter; E Kootwijk; M J Vaessen
Journal:  Hum Genet       Date:  1991-06       Impact factor: 4.132

2.  Top five medical innovations in China mainland since Xinhai revolution [1911]: results of AME survey-002.

Authors:  Yì-Xiáng J Wáng; Fan Xiao
Journal:  Quant Imaging Med Surg       Date:  2015-06

3.  Triple combination of retinoic acid plus actinomycin D plus dimethylformamide induces differentiation of human acute myeloid leukaemic blasts in primary culture.

Authors:  H T Hassan; J Rees
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

4.  Induction of erythroid differentiation by the anthracycline antitumor antibiotic pyrromycin.

Authors:  G Steinheider; A Schaefer; J Westendorf; H Marquardt
Journal:  Cell Biol Toxicol       Date:  1988-03       Impact factor: 6.691

5.  An anti-cancer derivative of butyric acid (pivalyloxmethyl buterate) and daunorubicin cooperatively prolong survival of mice inoculated with monocytic leukaemia cells.

Authors:  T Kasukabe; A Rephaeli; Y Honma
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

6.  Induced differentiation of human myeloid leukemia cells into M2 macrophages by combined treatment with retinoic acid and 1α,25-dihydroxyvitamin D3.

Authors:  Hiromichi Takahashi; Yoshihiro Hatta; Noriyoshi Iriyama; Yuichiro Hasegawa; Hikaru Uchida; Masaru Nakagawa; Makoto Makishima; Jin Takeuchi; Masami Takei
Journal:  PLoS One       Date:  2014-11-19       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.